In vivo quantification of tumor receptor binding potential with dual-reporter molecular imaging

Molecular Imaging and Biology

Volumn 14, Issue 5, 2012, Pages 584-592

  Tichauer, Kenneth M ^a   Samkoe, Kimberley S ^a,b   Sexton, Kristian J ^a   Hextrum, Shannon K ^a   Yang, Harold H ^a   Klubben, W Spencer ^a   Gunn, Jason R ^a   Hasan, Tayyaba ^c   Pogue, Brian W ^a,b,c  

^a DARTMOUTH COLLEGE   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Epidermal growth factor receptor; Fluorescence; Molecular imaging; Mouse model; Targeted reporter

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; GREEN FLUORESCENT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CELL DENSITY; CONTROLLED STUDY; EX VIVO STUDY; FEASIBILITY STUDY; FLOW CYTOMETRY; FLUORESCENCE IMAGING; GLIOBLASTOMA; GLIOSARCOMA; HUMAN; HUMAN CELL; IN VIVO STUDY; MALE; MOLECULAR IMAGING; MOUSE; NONHUMAN; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; QUANTITATIVE ANALYSIS; RECEPTOR BINDING; RECEPTOR DENSITY; SQUAMOUS CELL CARCINOMA; TUMOR VASCULARIZATION;

ANIMALS; CELL LINE, TUMOR; FLOW CYTOMETRY; FLUORESCENCE; HUMANS; MICE; MOLECULAR IMAGING; MOLECULAR PROBES; NEOPLASMS; RATS; RECEPTOR, EPIDERMAL GROWTH FACTOR; REPRODUCIBILITY OF RESULTS;

MUS;

EID: 84867254676     PISSN: 15361632     EISSN: 18602002     Source Type: Journal    
DOI: 10.1007/s11307-011-0534-y     Document Type: Article

References (28)

1. Weissleder R, Pittet MJ (2008) Imaging in the era of molecular oncology. Nature 452:580-589
2. Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, Langer R (2007) Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol 2:751-760
3. Ntziachristos V, Tung CH, Bremer C, Weissleder R (2002) Fluorescence molecular tomography resolves protease activity in vivo. Nat Med 8:757-760
4. Weissleder R, Tung CH, Mahmood U, Bogdanov A Jr (1999) In vivo imaging of tumors with protease-activated near-infrared fluorescent probes. Nat Biotechnol 17:375-378
5. Chernomordik V, Hassan M, Lee SB, Zielinski R, Gandjbakhche A, Capala J (2010) Quantitative analysis of Her2 receptor expression in vivo by near-infrared optical imaging. Mol Imaging 9:192-200
6. Mintun MA, Raichle ME, Kilbourn MR, Wooten GF, Welch MJ (1984) A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography. Ann Neurol 15:217-227
7. Lammertsma AA, Hume SP (1996) Simplified reference tissue model for PET receptor studies. Neuroimage 4:153-158
8. Logan J, Fowler JS, Volkow ND, Wang GJ, Ding YS, Alexoff DL (1996) Distribution volume ratios without blood sampling from graphical analysis of PET data. J Cereb Blood Flow Metab 16:834-840
9. Carmeliet P, Jain RK (2000) Angiogenesis in cancer and other diseases. Nature 407:249-257
10. Maeda H, Wu J, Sawa T, Matsumura Y, Hori K (2000) Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release 65:271-284
11. Goldenberg DM, Kim EE, DeLand FH, Bennett S, Primus FJ (1980) Radioimmunodetection of cancer with radioactive antibodies to carcinoembryonic antigen. Cancer Res 40:2984-2992
12. Hine KR, Bradwell AR, Reeder TA, Drolc Z, Dykes PW (1980) Radioimmunodetection of gastrointestinal neoplasms with antibodies to carcinoembryonic antigen. Cancer Res 40:2993-2996
13. Pogue BW, Samkoe KS, Hextrum S et al (2010) Imaging targeted-agent binding in vivo with two probes. J Biomed Opt 15:030513
14. Liu JT, Helms MW, Mandella MJ, Crawford JM, Kino GS, Contag CH (2009) Quantifying cell-surface biomarker expression in thick tissues with ratiometric three-dimensional microscopy. Biophys J 96:2405- 2414
15. Samkoe KS, Sexton K, Tichauer KM, et al. (2011) High vascular delivery of EGF, but low receptor binding rate is observed in AsPC-1 tumors as compared to normal pancreas. Mol Imaging Biol. doi:10.1007/s11307-011-5203-5
16. Innis RB, Cunningham VJ, Delforge J et al (2007) Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab 27:1533-1539
17. Samkoe KS, Chen A, Rizvi I et al (2010) Imaging tumor variation in response to photodynamic therapy in pancreatic cancer xenograft models. Int J Radiat Oncol Biol Phys 76:251-259
18. Wikstrand CJ, McLendon RE, Friedman AH, Bigner DD (1997) Cell surface localization and density of the tumor-associated variant of the epidermal growth factor receptor, EGFRvIII. Cancer Res 57:4130-4140
19. Gibbs-Strauss SL, Samkoe KS, O'Hara JA et al (2010) Detecting epidermal growth factor receptor tumor activity in vivo during cetuximab therapy of murine gliomas. Acad Radiol 17:7-17
20. Smith JJ, Derynck R, Korc M (1987) Production of transforming growth factor alpha in human pancreatic cancer cells: evidence for a superagonist autocrine cycle. Proc Natl Acad Sci USA 84:7567-7570
21. Gunn RN, Lammertsma AA, Hume SP, Cunningham VJ (1997) Parametric imaging of ligand-receptor binding in PET using a simplified reference region model. Neuroimage 6:279-287
22. Baselga J, Pfister D, Cooper MR et al (2000) Phase I studies of antiepidermal growth factor receptor chimeric antibody C225 alone and in combination with cisplatin. J Clin Oncol 18:904-914
23. Aerts HJ, Dubois L, Perk L et al (2009) Disparity between in vivo EGFR expression and 89Zr-labeled cetuximab uptake assessed with PET. J Nucl Med 50:123-131
24. McLarty K, Cornelissen B, Scollard DA, Done SJ, Chun K, Reilly RM (2009) Associations between the uptake of 111In-DTPA-trastuzumab, HER2 density and response to trastuzumab (Herceptin) in athymic mice bearing subcutaneous human tumour xenografts. Eur J Nucl Med Mol Imaging 36:81-93
25. Fujimori K, Covell DG, Fletcher JE, Weinstein JN (1990) A modeling analysis of monoclonal antibody percolation through tumors: a bindingsite barrier. J Nucl Med 31:1191-1198
26. Jain RK, Baxter LT (1988) Mechanisms of heterogeneous distribution of monoclonal antibodies and other macromolecules in tumors: significance of elevated interstitial pressure. Cancer Res 48:7022-7032
27. Tolmachev V, Rosik D, Wallberg H et al (2010) Imaging of EGFR expression in murine xenografts using site-specifically labelled anti- EGFR 111In-DOTA-Z EGFR:2377 affibody molecule: aspect of the injected tracer amount. Eur J Nucl Med Mol Imaging 37:613-622
28. Franceschini MA, Gratton E, Hueber D, Fantini S (1999) Near-infrared absorption and scattering spectra of tissues in vivo. In Proceedings of SPIE